Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

Clinical trial NCT03486457 · COMPLETED

Trial details

NCT number: NCT03486457
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2018-08-10
Primary completion: 2021-04-28
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.